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Setting: Tuberculosis (TB) and diabetes mellitus (DM) are prominent public health problems in the Re- 
public of the Marshall Islands, a small island nation with high rates of tuberculosis and diabetes. 
Objective: Evaluate the rate of active and latent TB in a Paciﬁc Island DM clinic. 
Design: In one DM clinic on the island of Ebeye, 213 adult patients aged 27–86 years completed tuber- 
culin skin testing and TB work-up between April 2010 and March 2012. 
Results: Screening for TB led to the diagnosis of 77 patients with TB infection and 11 patients with TB 
disease. From these data, the prevalence of TB disease among DM patients in the clinic exceeded 5% (95% 
CI 2.2%–8.1%). All patients who completed TB screening were at high risk of TB disease, and those with 
DM aged ≤ 50 years had a higher risk of TB disease than those with DM over age 50 (RR 3.1, C.I. 1.0–9.7, 
p = 0.05). 
Conclusion: The experience at the Ebeye Diabetes Clinic demonstrates that screening DM patients for TB 
can identify signiﬁcant rates of TB infection and TB disease, and should be considered for other settings 
with a high background TB incidence. Further assessment of TB risks should explore age, gender, and 
level of diabetes control. 
© 2016 Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ). 
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i  1. Introduction 
Tuberculosis (TB) and diabetes mellitus (DM) are highly preva-
lent in the U.S. Aﬃliated Paciﬁc Islands (USAPI) which include
American Samoa, Commonwealth of the Northern Mariana Islands,
Federated States of Micronesia, Guam, Palau, and Republic of the
Marshall Islands (RMI). Despite recent improvements in regional
TB control, the reported 2013 TB incidence rate in the USAPI was
76.6 cases per 10 0,0 0 0 persons, compared to the overall U.S. na-
tional TB case rate (for the 50 States and the District of Columbia,
exclusive of territories) of 3.0 per 10 0,0 0 0 [1] . The prevalence of
TB in the RMI is the highest in the USAPI at 215 per 10 0,0 0 0 [1] .
To add to this, the prevalence of type 2 diabetes among adults in
the Marshall Islands is 41%, one of the highest reported DM rates
in the world [2] . ∗ Corresponding author. 
E-mail address: hld4@cdc.gov (R. Brostrom). 
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2405-5794/© 2016 Published by Elsevier Ltd. This is an open access article under the CCIn response to growing awareness of the convergence of DM
nd TB in USAPI, the Paciﬁc Island TB Controllers Association
PITCA) has adopted a set of clinical practice standards, the USAPI
tandards for the Management of Tuberculosis & Diabetes [3] . These
tandards were proposed in 2006, were reviewed by regional ex-
erts, and were formally adopted by USAPI public health authori-
ies in December 2010. In parallel to the overarching WHO Collab-
rative Framework for Care and Control of Tuberculosis and Diabetes
4] , the USAPI TB-DM Standards include recommendations for bidi-
ectional TB and DM screening, strategies for glucose control dur-
ng TB treatment, DM education during TB treatment, and clinical
ractices to improve TB-DM patient outcomes. 
The USAPI TB-DM Standards are being followed in several loca-
ions, including the RMI. Ebeye is a remote island of 9614 people
n RMI’s Kwajalein Atoll in the North Paciﬁc, and it represents one
f two population centers in RMI [5] . This study assesses the im-
act of TB screening in Ebeye among DM patients presenting for
outine DM care. The screening paradigm used by the program isBY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ). 
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Fig. 1. Tuberculosis (TB) screening results among people with diabetes mellitus, Ebeye Island, 2010–2012 ( N = 353). 
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Table 1 
Tuberculosis (TB) screening compliance among adults with diabetes 
mellitus by gender and age, Ebeye Island, 2010–2012 ( N = 353). 
Category Completed TB 
screening 
Did not complete 
TB screening 
p value 
Number 213 140 –
Age 56 .4 54 .7 p = 0.11 
% Male 32% 22% p = 0.04 
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d  escribed, and results of TB screening for ﬁnding latent TB infec-
ion (LTBI) and TB disease are discussed. 
. Study population and methods 
Ethics approval was obtained from the Institutional Review
oard (IRB) in the RMI Ministry of Health. The study also under-
ent ethical review at the Centers for Disease Control (CDC) and
as determined to be research that was exempt from CDC IRB re-
iew on the basis of this being limited to a program evaluation
ctivity. 
Over a 24-month period between April 2010 and March 2012,
53 DM patients were offered a tuberculin skin test (TST). All
esting was done at the Ebeye Diabetes Clinic as part of routine
M management. TB program staff visited the weekly half-day
M clinics to provide TB skin-testing. TB staff encouraged DM pa-
ients to participate in TB screening, but patient participation was
oluntary. 
Clinic nurses administered TSTs and recorded results in the DM
linic logbook and patient records. Patients were scheduled to re-
urn to the DM clinic 48–72 h later for skin test interpretation. Pa-
ients with a TST ≥ 10 mm were referred to the Ebeye TB Clinic
or chest x-ray (CXR) and further examination. The Ebeye TB clin-
cian interpreted the CXR and, if consistent with TB disease, or-
ered sputum for acid-fast bacillus (AFB) smear microscopy in Eb-
ye. Sputum specimens were also sent to Diagnostic Laboratory
ervices in Honolulu for AFB culture. Drug susceptibility testing
DST) was obtained on all samples with a positive Mycobacterium
uberculosis culture. Spoligotype and 24-locus Mycobacterial inter-
persed repetitive units (24-locus MIRU-VNTR was performed on
ulture conﬁrmed TB isolates that were submitted using the Na-
ional Tuberculosis Genotyping Service [6] . Follow-up and manage-
ent for TB were directed through the Ebeye TB Program. Preven-
ive treatment (principally with 9 months of isoniazid) was offered
o patients with diabetes who were diagnosed with LTBI. 
For patients completing TB screening, rates of active TB were
ompared for patients age ≤50 years and those > 50 years old us-
ng Epi-Info 7 [7] to obtain the risk ratio (RR) and the 95% con-
dence interval (CI); Fischer’s two-tailed exact test was used to
etermine the probability [8] . The signiﬁcance level for statistical
nalyses was p ≤ 05. 
. Results 
A diagram of the screening methodology is depicted in Fig. 1 .
 total of 353 patients with DM aged 27–86 years received a TST
rom April 2010 to March 2012. Of the total, only 213 (60%) had
he TST read and documented. Among those who completed ini-
ial TB screening, 88 (41%) had a positive result, i.e., TST induration
10 mm. All these patients underwent CXR, and those with abnor-
al CXR ﬁndings underwent sputum collection for acid-fast bacil-
us (AFB) smear and culture. Among the 88 patients with a posi-ive TST result, 11 cases of TB disease and 77 cases of LTBI were
iagnosed. The isolate from one patient was multi-drug resistant
MDR) TB and the rest of the isolates were susceptible to isoni-
zid, rifampin, ethambutol and pyrazinamide. Five of the 11 cases
45%) were smear positive and six of the TB cases (54%) were cul-
ure positive. Genotype results were available for three out of the
ix (50%) culture positive cases, and all three had the same Lin-
age 2 (East-Asian, formerly known as Beijing) genotype (GENType
0 0 017) [9] . 
Of the ﬁve culture-negative cases, 4 (36%) were clinically di-
gnosed with radiographic changes. Overall, 10 cases were pul-
onary TB and one case (9%) was both pulmonary and extra-
ulmonary TB. From this screening effort, the rate of TB disease
mong DM patients on Ebeye was 5200 per 10 0,0 0 0 (5.2%; 95%
I 2.2% −8.1%), based on 11 TB cases identiﬁed and treated from
mong the 213 patients who completed the initial screening. 
Differences in patient characteristics among those who com-
leted TST screening and those who failed to complete TST screen-
ng are listed in Table 1 . There was no difference in age between
he compliant and non-compliant groups, but the percentage of
ales who completed screening was signiﬁcantly higher than
emales. 
Further assessment of the TB case rate among patients with DM
n Ebeye reveals an association with age among the 210 individu-
ls who completed screening and for whom age data were avail-
ble ( Table 2 ). Although TB disease was highly prevalent among
ll adults who completed screening (11/210, or 5200 per 10 0,0 0 0),
dults with DM ≤50 years of age had greater prevalence (6/56,
r 10,700 per 10 0,0 0 0) than those > 50 years (5/154, or 3200 per
0 0,0 0 0) (RR 3.1, C.I. 1.0–9.7, p = 0.05). 
. Discussion 
In the Ebeye Diabetes Clinic over a 2-year period, 213 patients
ere tuberculin skin tested, which resulted in diagnosing 77 with
TBI and 11 with TB disease. Recent reviews have underscored the
ynergistic effect of TB and DM, particularly the effect of DM on
rogression of TB infection to TB disease, the complexity of treat-
ent when both diseases are present, and the potential value of
idirectional screening [10] . Systematic reviews and meta-analyses
f observational studies have demonstrated a relative risk of TB
isease developing in DM patients of 3.1 in populations with high
6 R.M. Trinidad et al. / Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 5 (2016) 4–7 
Table 2 
Results of tuberculosis (TB) screening in among adults with diabetes mellitus by gender and age, Ebeye Island, 
2010–2012 ( N = 353). 
Completed TB screening TST < 10 mm TST ≥10 mm Latent TB Active TB p value ∗
All 213 125 (59%) 88 (41%) 77 (35%) 11 (5 .2%) 
Age ≤50 56 31 (55%) 25 (45%) 19 (34%) 6 (10 .7%) RR 3.1 
Age > 50 154 91 (59%) 63 (41%) 57 (37%) 5 (3 .2%) p = 0.05 
(1 .0–9.7) 
Males 69 38 (55%) 31 (45%) 26 (38%) 5 (7 .2%) RR 1.7 
p = 0.28 
Females 144 87 (60%) 57 (40%) 51 (35%) 6 (4 .2%) (0 .5–5.4) 
∗ Probabilities refer to rate of TB disease comparing persons ≤50 years with persons > 50 years, and comparing 
males with females. 
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W  TB incidence, as well as a greater prevalence of DM among TB pa-
tients [10–12] . 
DM is exceptionally common among Paciﬁc Islanders. Urbaniza-
tion, increasing poverty, a westernized diet, and physical inactivity
have been implicated [13,14] . Based upon the overwhelming inci-
dence of DM and other non-communicable diseases, several Pa-
ciﬁc Island nations have oﬃcially declared national health disas-
ters [15] . Unfortunately, the burden of DM is predicted to increase
dramatically in low-income and middle-income countries over the
next two decades, as the result of population growth, aging, dietary
changes, and continued physical inactivity [16] . For the Paciﬁc, this
study is consistent with an impact of DM on local TB incidence
rates, and it underscores the necessity of TB and DM program in-
tegration in effort s to achieve long-term TB control. 
In different settings, the observed strength of association be-
tween TB and DM varies considerably, based upon the local preva-
lence of each disease [10–17] . Although the number of patients
with TB was small, this study revealed high rates of TB disease
among patients awaiting routine care in the Ebeye DM Clinic over
a 2-year period. The more than 5% rate of TB disease over a 2-year
period among DM patients in Ebeye is alarming, but prior reports
from other high TB-incidence countries have shown similar ﬁnd-
ings [18,19] . 
The task of stratifying TB risk among people with diabetes is
essential for successful implementation of bidirectional screening.
A recent study from southern Mexico determined the risk for pro-
gression to TB disease among persons with DM to be inversely re-
lated to age [12] . For this study, the risk of TB disease among per-
sons with DM was high for all age groups, but further evaluation
demonstrated the risk for TB disease was signiﬁcantly higher in
persons ≤50 years old than it was for persons over age 50. 
Overall, the observed rate of TB disease among those who com-
pleted TB screening in the Ebeye DM clinic over a 2-year period
was more than 20 times higher than that reported for the RMI
general population in 2012 (5200 vs. 215 per 10 0,0 0 0) [1] . It is
likely that some of the difference can be explained by the pres-
ence of diabetes as well as the active TB case-ﬁnding process in
this high-incidence setting. 
Genotyping data were used to assess the possibility that high
rates of TB in the Ebeye DM clinic represented an actual DM clinic-
associated outbreak, rather than an overall high rate of TB among
adults with diabetes in Ebeye. Only three of these TB cases were
genotyped, but all three shared the same genotype (G0 0 017), rais-
ing the possibility of a localized cluster of TB cases related to at-
tendance at the DM clinic. However, there are limitations when in-
terpreting genotyping data for identifying TB clusters in the US Pa-
ciﬁc, because many common Lineage 2 (East Asian) strains are not
well differentiated. The G0 0 017 strain is the most frequently re-
ported genotype in the United States Aﬃliated islands [1] . Among
all genotypes found in the Marshall Islands in 2010 and 2011, this
same genotype accounts for 57% (68/120) of TB cases. Similar clus-
tering among East Asian strains, possibly related to on-going trans- n  ission, has been reported in Kiribati, a neighboring Paciﬁc Island
roup [20] . 
Screening persons who had DM with a TST substantially added
o overall TB case ﬁnding effort s f or the RMI TB Program. Active
B screening in persons with DM can lead to earlier TB diagnosis,
nd may lead to improved TB treatment outcomes and less trans-
ission of TB. Additional research is underway to evaluate TB pre-
entation and treatment outcomes among persons with diabetes in
he USAPI. 
This evaluation had several limitations. First, although the TB
ase rate was high, the number of cases was small. As other US-
PI jurisdictions progress towards full implementation of the US-
PI TB-DM Standards, it may be possible to pool results of sev-
ral island groups for a more robust analysis. Additionally, there
as no assessment of the degree of diabetes control relative to TB
creening outcomes among the patients. Other studies have found
hat the risk for progression to TB disease among DM patients with
TBI was strongly correlated with overall glucose control as mea-
ured by hemoglobin A 1 c, or the presence of diabetic complica-
ions [21,22] . Paciﬁc programs are working to characterize the de-
ree of diabetes control at the time of TB diagnosis and incorpo-
ate the results into routinely collected surveillance data. Third, as
oted, genotyping data were only available on three of the cases;
lthough sharing the same genotype commonly found in the RMI,
hese isolates were not subjected to whole genome sequencing
hat would give a better indication as to whether these cases were
elated through recent transmission. 
Finally, there are two issues with the use of TST for initial TB
creening. While the TST is the only currently available test for the
iagnosis of latent TB, the TST does not perform well in a patient
ith active TB disease and can miss up to 30% of prevalent cases
23] . Operationally, almost 40% of the patients who received a TST
id not return for skin test reading, and consequently were not in-
luded in the analysis. Preliminary analysis indicated that males
ere signiﬁcantly more likely to complete initial TB screening, and
able 2 indicated that males tended to have higher TB rates than
emales. Additional bias in the results may have also introduced
epending on whether patients who were unable to complete the
ST reading were more likely to have a negative TST. Other ac-
ive case ﬁnding methodologies have been used in DM clinics to
mprove success with TB screening [24] . Future implementation of
he USAPI TB-DM Standards should focus on strategies to increase
ompletion of TST readings among people with DM, with consider-
tion for another strategy that is more sensitive for active TB, such
s periodic chest X-ray. 
. Conclusions 
The results from TB screening with TST in the Ebeye DM Clinic
nderscore the importance of TB-DM screening advocated by the
HO Framework and the USAPI TB-DM Standards as an opportu-
ity for TB case-ﬁnding as well as treatment of LTBI in this high-
R.M. Trinidad et al. / Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 5 (2016) 4–7 7 
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 isk group. Improved integration of TB and DM programs with con-
inued implementation of USAPI TB-DM Standards can contribute
o reducing the disparity in TB incidence between the USAPI and
ther U.S. jurisdictions. 
Continued program collaboration between TB and DM programs
ill help to integrate once-vertical public health programs, and
hift programs towards enhanced patient-centered care, possibly
eading to improved patient outcomes for those with TB disease. As
rofound dietary and lifestyle changes continue to add signiﬁcantly
o the global burden of DM, other countries with high TB rates may
eneﬁt from adapting policies consistent with the WHO Collabora-
ive Framework for Care and Control of Tuberculosis and Diabetes and
rom implementing standards and clinical guidelines similar to the
SAPI Standards for the Management of Tuberculosis & Diabetes. 
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